MedPath

Role of yoga in reducing swelling and other harmful substances responsible for diabetic complications in Diabetes patients

Not Applicable
Completed
Conditions
Health Condition 1: null- Confirmed cases of type 2 Diabetes mellitus patients according to American Diabetes Association(ADA)/European Association of Study of Diabetes criteria(EASD)
Registration Number
CTRI/2017/08/009447
Lead Sponsor
Sonal Bhardwaj
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
104
Inclusion Criteria

1.Confirmed cases of type 2 Diabetes mellitus patients according to American Diabetes Association(ADA)/European Association of Study of Diabetes criteria(EASD) ( Fasting Blood glucose (FBS) �126mg/dl and Post-Prandial blood glucose �200 mg/dl, HbA1c �6.5).

2.Patient already on diabetic treatment.

Exclusion Criteria

1.Patients of acute and chronic infections

2.Connective tissue disease

3.Seriously ill patients

4.Inability to give informed consent

5.History of viral infections in the last one year

6.Patients with claims for myalgia, myositis and myopathy

7.Cancer,Pulmonary tuberculosis

8.Haemolytic disease, Chronic Obstructive Pulmonary Disease(COPD)

9.Bronchial Asthma ,Rheumatoid arthritis

Additional Exclusion Criteria for subgroup 1B and 2B (Patients of type 2 Diabetes mellitus without complications group)

1.Micro vascular Complications

2.Proliferative or pre-proliferative retinopathy

3.Nephropathy including micro-albuminuria, Known or suspected

4.Autonomic neuropathy

5.Advanced nephropathy with renal failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of yoga intervention on inflammatory markers and oxidative stress markers in patients of type 2 Diabetes mellitus.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
To study the effect of yoga on glycemic control, body weight and quality of life in patients of type 2 Diabetes mellitus.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath